Back to Results
First PageMeta Content
Bristol-Myers Squibb / Ipilimumab / Immunotherapy / Melanoma / End point of clinical trials / Interleukin 2 / Immune system / James L. Gulley / Cancer vaccine / Medicine / Immunology / Cancer treatments


Published in June[removed]Clinical Trial Solutions Copyright 2014 by PharmaLinx LLC
Add to Reading List

Document Date: 2014-06-03 16:37:54

Open Document

File Size: 102,70 KB

Share Result on Facebook

Company

AEs / PharmaLinx LLC / /

Event

FDA Phase / /

IndustryTerm

clinical trial solution / drug development services / biotechnology industries / /

MedicalCondition

tumor / inflammatory reaction / cancer / tumors / disease / stable disease / inflammatory phenomena / hepatitis / dermatitis / mostly inflammatory cells / progressive disease / advanced melanoma / metastatic melanoma / /

MedicalTreatment

immunosuppressive therapy / immunotherapies / immunotherapy / /

Person

JEFFREY WEISBERG / /

Position

Vice President / Medical Affairs / /

Product

pseudo / FS / IMMUNO-ONCOLOGY DRUG / /

Technology

biotechnology / drug development / /

SocialTag